Jeremy Van't Hof, MD, MS

Assistant Professor of Medicine, Cardiovascular Division

Jeremy Van't Hof

Contact Info

Mailing Address:
420 Delaware ST SE
MMC 508
Minneapolis, MN 55455

Administrative Assistant Name
Roberta Beach

Administrative Email
rmbeach@umphysicians.umn.edu

Additional Locations

M Health Fairview Clinics & Surgery Center

Assistant Professor of Medicine, Cardiovascular Division

Director, Cardiac Rehabilitation, UMMC

Associate Director, Rasmussen Center for Cardiovascular Disease Prevention


Preventive Cardiologist


MD, Loma Linda University

Internal Medicine Residency, University of Minnesota

Cardiovascular Medicine Fellowship, University of Minnesota

MS, University of Minnesota

BA, Calvin College

Summary

Jeremy Van’t Hof is a Minnesota native who traveled to Michigan for undergraduate training in biochemistry (Calvin College) and then to California for medical school (Loma Linda University). Informing his lifelong interest in public health, he spent a key five month period in Honduras as a rural health clinic volunteer performing rural medicine outreach. He returned to Minnesota in 2012 in order to complete an Internal Medicine Residency and Cardiovascular Medicine Fellowship at the University of Minnesota.

Dr. Van’t Hof’s clinical interests include early detection of cardiovascular disease in order to prevent or delay the onset of cardiovascular events, familial hypercholesterolemia, resistant hypertension and complex polyvascular disease. He believes in an integrative treatment approach combining lifestyle alterations with evidence based medical therapy to maximize physical and mental health as well as quality of life.

Dr. Van’t Hof’s research interest involves improving cardiovascular disease detection and early intervention. He believes that poor cardiovascular health is often a result of poor public health literacy, linked to inefficiencies created by the current “sickness-based” health care delivery system. The failure of cardiovascular prevention is a key factor that leads individuals to a less happy, less productive, and shorter life. Dr. Van’t Hof is dedicated to all efforts that improve both individual cardiovascular health and population health through public health research and intervention.

Awards & Recognition

  • Alan T. Hirsch Vascular Award, University of Minnesota Cardiovascular Division (2017)
  • Anthony L Garofalo Cardiovascular Disease Prevention Award, University of Minnesota (2016)
  • Yang Wang Fellowship Research Award, University of Minnesota Cardiovascular Division (2015)
  • Best Teacher Award, University of Minnesota Internal Medicine Residency

Research

Research Summary/Interests

  • Early cardiovascular disease detection and intervention
  • Appropriate screening for cardiovascular diseases
  • Bridging the gap between public health and precision medicine

Publications

Click here to access a complete list of Dr. Van’t Hof’s publications.

  • Van't Hof JR, Duval S, Oldenburg NC, Misialek JR, Eder MM, Jones C, Finnegan JR, Luepker RV. Low-dose aspirin for primary prevention of cardiovascular disease: Trends in use patterns among African American adults in Minnesota, 2015-2019. Prev Med. 2021 Jul;148:106589. doi: 10.1016/j.ypmed.2021.106589.
  • Honda Y, Mok Y, Mathews L, Van’t Hof JR, Daumit G, Kucharska-Newton A, Selvin E, Mosley T, Coresh J, Matsushita K. Psychosocial factors and subsequent risk of hospitalizations with peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2021 May 9:S0021-9150(21)00223-9. doi: 10.1016/j.atherosclerosis.2021.04.020.
  • Luepker RV, Oldenburg NC, Misialek JR, Van't Hof JR, Finnegan JR, Eder M, Duval S. Aspirin Use and Misuse for the Primary Prevention of Cardiovascular Diseases. Am J Prev Med. 2021 Apr;60(4):513-519. doi: 10.1016/j.amepre.2020.10.025.
  • Misialek JR, Van't Hof JR, Oldenburg NC, Jones C, Eder M, Luepker RV, Duval S. Aspirin Use and Awareness for Cardiovascular Disease Prevention Among Hispanics: Prevalence and Associations with Health Behavior Beliefs. J Community Health. 2020 Aug;45(4):820-827. doi: 10.1007/s10900-020-00798-9.
  • Van't Hof JR, Duval S, Misialek JR, Oldenburg NC, Jones C, Eder M, Luepker RV. Aspirin Use for Cardiovascular Disease Prevention in an African American Population: Prevalence and Associations with Health Behavior Beliefs. J Community Health. 2019 Jun;44(3):561-568. doi: 10.1007/s10900-019-00646-5.
  • Van’t Hof JR, Miedema MD. Primary Prevention of Cardiovascular Disease in Individuals With Type 2 Diabetes: Time for Cardiology to Get Back in the Game. http://www.acc.org. May 8, 2019. https://www.acc.org/latest-in-cardiology/articles/...
  • Van't Hof JR, Duval S, Walts A, Kopecky SL, Luepker RV, Hirsch AT. Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007-2015: A Serial, Cross-sectional Study. J Am Heart Assoc. 2017 Oct 3;6(10):e006328. doi: 10.1161/JAHA.117.006328. 

Teaching

Academic Interests and Focus

Cardiovascular Physiology; Lipid disorders

Clinical

Clinics

Clinics and Surgery Center

Clinical Interests

Cardiovascular disease prevention (primary, secondary), Early detection of cardiovascular disease, Epidemiology, Familial hypercholesterolemia, Lipid/cholesterol disorders, Premature atherosclerosis, Resistant hypertension, Wellness/Integrative Medicine

Hospital Privileges

M Health Fairview University of Minnesota Medical Center, Rasmussen Center for Cardiovascular Disease Prevention